Allowance to extend into 2036 patent claims related to method of treating patients with A-T using the company’s proprietary EryDex process Charles Ryan, J.D., Ph.D., Quince’s President and head of the ...
VANCOUVER, British Columbia, April 17, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0 ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results